FLT190

DB18420InvestigationalGene Therapies

FLT190 is a recombinant adeno-associated viral vector serotype S3 containing DNA encoding for human alpha-galactosidase A.

Code names
FLT-190

What you can answer from here — as of September 25, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of FLT190, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In